Threshold Values of High‐risk Echocardiographic Epicardial Fat Thickness
Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and a...
Saved in:
Published in | Obesity (Silver Spring, Md.) Vol. 16; no. 4; pp. 887 - 892 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2008
|
Subjects | |
Online Access | Get full text |
ISSN | 1930-7381 1930-739X |
DOI | 10.1038/oby.2008.6 |
Cover
Abstract | Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors.
Methods and Procedures: Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30–65), median BMI 32 kg/m2 (22–52), median waist circumference 100.5 cm (85–140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated.
Results: Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance.
Discussion: Median values of 9.5 and 7.5 mm should be considered the threshold values for high‐risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat. |
---|---|
AbstractList | Objective:
Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors.
Methods and Procedures:
Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30–65), median BMI 32 kg/m
2
(22–52), median waist circumference 100.5 cm (85–140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated.
Results:
Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (
P
< 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance.
Discussion:
Median values of 9.5 and 7.5 mm should be considered the threshold values for high‐risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat. Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors.OBJECTIVEEchocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors.Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated.METHODS AND PROCEDURESEpicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated.Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance.RESULTSAmong 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance.Median values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.DISCUSSIONMedian values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat. Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Median values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat. Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Methods and Procedures: Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30–65), median BMI 32 kg/m2 (22–52), median waist circumference 100.5 cm (85–140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Results: Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Discussion: Median values of 9.5 and 7.5 mm should be considered the threshold values for high‐risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat. Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Median values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat. |
Author | Barbaro, Giuseppe Sharma, Arya M. Willens, Howard J. Iacobellis, Gianluca |
Author_xml | – sequence: 1 givenname: Gianluca surname: Iacobellis fullname: Iacobellis, Gianluca – sequence: 2 givenname: Howard J. surname: Willens fullname: Willens, Howard J. – sequence: 3 givenname: Giuseppe surname: Barbaro fullname: Barbaro, Giuseppe – sequence: 4 givenname: Arya M. surname: Sharma fullname: Sharma, Arya M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18379565$$D View this record in MEDLINE/PubMed |
BookMark | eNp90cFKAzEQBuAgFW2rFx9AFgQPwtZkk91kj1qqVYReiugpZLNTN3a7qckW6c1H8Bl9EqNVDyKeEoZvfoaZHuo0tgGEDggeEEzFqS3WgwRjMci2UJfkFMec5nedn78gu6jn_SPGLMMp2UG7RFCep1naRdfTyoGvbF1Gt6pegY_sLBqbh-rt5dUZP49GurJaudLYB6eWldHRaGk-C6qOLlQbTUNt3oD3e2h7pmoP-19vH00vRtPhOL6ZXF4Nz25izVLGY50IJZQSmOi8KNOU5EpjQhgDTspUFCXnQEgpgGrGZwUUuKAp5CyDolQgaB8db2KXzj6FgVu5MF5DXasG7MpLjhlLCCcBHv2Cj3blmjCaDGvDLKFJwoM6_FKrYgGlXDqzUG4tv1cUAN4A7az3DmZSm1a1xjatU6YOWR9xQoYryI8ryCy0nPxq-Un9Cw82-NnUsP5Hysn5fU45fQfNf5do |
CitedBy_id | crossref_primary_10_3390_jcdd9080253 crossref_primary_10_1111_pace_13119 crossref_primary_10_1007_s10554_015_0778_8 crossref_primary_10_3390_ijms20235989 crossref_primary_10_1371_journal_pone_0019908 crossref_primary_10_1038_s41390_024_03319_9 crossref_primary_10_2217_17584299_4_1_55 crossref_primary_10_1016_j_diabres_2010_09_037 crossref_primary_10_1097_CRD_0000000000000670 crossref_primary_10_4250_jcu_2009_17_4_121 crossref_primary_10_1016_j_endonu_2013_03_004 crossref_primary_10_1016_j_jcmg_2010_05_003 crossref_primary_10_1016_j_jicc_2017_01_003 crossref_primary_10_1038_oby_2011_283 crossref_primary_10_15436_2376_0494_15_034 crossref_primary_10_3945_ajcn_2008_27358 crossref_primary_10_1515_jim_2017_0090 crossref_primary_10_1007_s00059_017_4555_4 crossref_primary_10_1161_CIRCULATIONAHA_107_721027 crossref_primary_10_3390_biom9030097 crossref_primary_10_1007_s10554_022_02579_y crossref_primary_10_3390_jcm11164718 crossref_primary_10_1016_j_jcmg_2010_05_001 crossref_primary_10_1210_jc_2009_0436 crossref_primary_10_1177_0003319714548211 crossref_primary_10_1007_s10741_017_9644_1 crossref_primary_10_1111_j_1399_5448_2010_00644_x crossref_primary_10_3109_10641963_2013_863324 crossref_primary_10_1016_j_clnu_2008_10_006 crossref_primary_10_1016_j_jacl_2016_02_006 crossref_primary_10_1159_000484326 crossref_primary_10_1016_j_exger_2012_09_005 crossref_primary_10_7326_aimcc_2022_0056 crossref_primary_10_1515_jce_2017_0003 crossref_primary_10_31832_smj_486781 crossref_primary_10_2169_internalmedicine_54_3714 crossref_primary_10_1016_j_hipert_2010_12_003 crossref_primary_10_1038_oby_2011_155 crossref_primary_10_2147_JIR_S326769 crossref_primary_10_1016_j_atherosclerosis_2012_07_014 crossref_primary_10_1016_j_arcmed_2017_06_010 crossref_primary_10_1053_j_jvca_2019_08_053 crossref_primary_10_1177_0003319712450310 crossref_primary_10_1016_j_biomag_2011_06_001 crossref_primary_10_1177_10742484211006997 crossref_primary_10_1016_j_cjca_2025_01_029 crossref_primary_10_1177_1479164119827602 crossref_primary_10_1016_j_ebiom_2022_103864 crossref_primary_10_3390_nu14142926 crossref_primary_10_1021_pr500434s crossref_primary_10_31146_1682_8658_ecg_222_2_101_110 crossref_primary_10_1016_j_atherosclerosis_2014_12_058 crossref_primary_10_3390_ijerph18063136 crossref_primary_10_1016_j_recesp_2013_10_013 crossref_primary_10_1152_ajpheart_00175_2014 crossref_primary_10_1016_j_numecd_2021_10_011 crossref_primary_10_1016_j_nut_2018_07_002 crossref_primary_10_1111_pedi_12893 crossref_primary_10_1038_oby_2008_575 crossref_primary_10_1016_S2171_3669_11_70023_3 crossref_primary_10_1093_eurheartj_ehr453 crossref_primary_10_3390_jcm7050113 crossref_primary_10_1016_j_numecd_2022_08_005 crossref_primary_10_1016_j_ejogrb_2021_12_020 crossref_primary_10_1186_s12933_017_0528_4 crossref_primary_10_1038_oby_2009_363 crossref_primary_10_1186_1757_2215_7_24 crossref_primary_10_1080_07315724_2014_933685 crossref_primary_10_1155_2015_456293 crossref_primary_10_1016_j_recesp_2016_07_025 crossref_primary_10_16899_jcm_577187 crossref_primary_10_1016_j_numecd_2022_03_003 crossref_primary_10_1016_j_rec_2013_10_011 crossref_primary_10_36660_ijcs_20190179 crossref_primary_10_4239_wjd_v11_i2_33 crossref_primary_10_1016_j_amjcard_2012_08_044 crossref_primary_10_1016_j_echo_2009_10_013 crossref_primary_10_1371_journal_pone_0074926 crossref_primary_10_1016_j_echo_2010_11_008 crossref_primary_10_20538_1682_0363_2018_4_254_263 crossref_primary_10_1111_j_1476_5381_2011_01479_x crossref_primary_10_1016_j_numecd_2016_11_001 crossref_primary_10_1016_j_jelectrocard_2020_05_009 crossref_primary_10_1016_j_echo_2011_09_018 crossref_primary_10_1007_s00246_013_0799_9 crossref_primary_10_25259_IJDVL_214_19 crossref_primary_10_5812_cardiovascmed_4_2_2015_25679 crossref_primary_10_1186_1471_2261_14_3 crossref_primary_10_1016_j_amjcard_2011_07_031 crossref_primary_10_1186_s12944_016_0371_8 crossref_primary_10_20862_0042_4676_2019_100_6_387_394 crossref_primary_10_4178_epih_e2023001 crossref_primary_10_1007_s11845_020_02339_8 crossref_primary_10_1016_j_numecd_2015_10_013 crossref_primary_10_1007_s40618_014_0199_x crossref_primary_10_1016_j_tria_2022_100175 crossref_primary_10_1016_j_endoen_2012_08_013 crossref_primary_10_14341_omet9295 crossref_primary_10_1177_2047487317724342 crossref_primary_10_1007_s12020_024_04077_8 crossref_primary_10_1016_j_endoen_2011_06_002 crossref_primary_10_4236_ijcm_2011_24062 crossref_primary_10_1016_j_amjcard_2010_01_368 crossref_primary_10_1111_echo_13600 crossref_primary_10_1155_2013_769175 crossref_primary_10_1007_BF03346676 crossref_primary_10_36660_ijcs_20200363 crossref_primary_10_1016_j_numecd_2011_09_001 crossref_primary_10_1161_CIRCRESAHA_115_307765 crossref_primary_10_1038_nrendo_2015_58 crossref_primary_10_1016_j_atherosclerosis_2012_05_033 crossref_primary_10_1016_j_atherosclerosis_2021_02_008 crossref_primary_10_1002_ejhf_2709 crossref_primary_10_1016_j_ehj_2018_04_002 crossref_primary_10_1016_j_numecd_2020_11_005 crossref_primary_10_1016_j_rec_2016_08_001 crossref_primary_10_14341_omet2018229_34 crossref_primary_10_1016_j_numecd_2015_04_011 crossref_primary_10_1016_j_cjca_2014_12_008 crossref_primary_10_1049_iet_spr_2011_0170 crossref_primary_10_1186_s12933_017_0650_3 crossref_primary_10_1093_cvr_cvz062 crossref_primary_10_14341_omet12614 crossref_primary_10_1016_j_endoen_2013_12_007 crossref_primary_10_1007_s00059_014_4146_6 crossref_primary_10_1016_j_numecd_2008_06_007 crossref_primary_10_1111_ijpo_227 crossref_primary_10_1016_j_jchf_2020_04_016 crossref_primary_10_1111_j_1582_4934_2010_01141_x crossref_primary_10_1002_mco2_413 crossref_primary_10_1016_j_ijcard_2012_06_011 crossref_primary_10_1016_j_echo_2015_07_006 crossref_primary_10_1097_MEG_0000000000002375 crossref_primary_10_1007_s40618_014_0066_9 crossref_primary_10_1089_met_2013_0107 crossref_primary_10_1016_j_cgh_2018_11_011 crossref_primary_10_1016_j_numecd_2023_10_016 crossref_primary_10_1016_j_endonu_2011_06_002 crossref_primary_10_1111_j_2047_6310_2012_00134_x crossref_primary_10_1002_oby_20090 crossref_primary_10_1016_j_numecd_2017_05_009 crossref_primary_10_1002_cbf_1706 crossref_primary_10_1016_j_numecd_2020_03_016 crossref_primary_10_1016_j_tem_2011_07_003 crossref_primary_10_1080_10641955_2017_1321016 crossref_primary_10_1016_j_arteri_2011_08_003 crossref_primary_10_1016_S1575_0922_08_75079_4 crossref_primary_10_18621_eurj_1180149 crossref_primary_10_1007_s12020_013_0099_4 crossref_primary_10_1016_j_amjcard_2009_07_032 crossref_primary_10_7759_cureus_51698 crossref_primary_10_1186_s12872_020_01480_7 crossref_primary_10_13048_jkm_17043 crossref_primary_10_1007_s00508_015_0722_x crossref_primary_10_3390_biology11030355 crossref_primary_10_1007_s40477_019_00368_3 crossref_primary_10_1038_ajh_2011_134 crossref_primary_10_1016_j_amjcard_2012_07_045 crossref_primary_10_1016_j_atherosclerosis_2017_06_017 crossref_primary_10_1177_2047487317717820 crossref_primary_10_3390_jcm10225455 crossref_primary_10_1016_j_ijcard_2018_06_106 crossref_primary_10_1007_s12020_014_0460_2 crossref_primary_10_3109_08037051_2011_649538 crossref_primary_10_3390_ijms24076838 crossref_primary_10_1016_j_endonu_2012_08_001 crossref_primary_10_1007_s15034_020_2137_7 crossref_primary_10_1016_j_bionut_2011_06_024 crossref_primary_10_3109_14017431_2013_824604 crossref_primary_10_1016_j_amjcard_2012_06_003 crossref_primary_10_18705_1607_419X_2022_28_3_260_269 crossref_primary_10_1177_11795468211041330 crossref_primary_10_1186_1743_8977_10_43 crossref_primary_10_3390_ijms21020520 crossref_primary_10_1159_000488064 crossref_primary_10_1007_s11739_022_02966_2 crossref_primary_10_1038_ijo_2011_117 crossref_primary_10_3389_fcvm_2021_658445 crossref_primary_10_1186_1476_7120_12_35 crossref_primary_10_1007_s12350_015_0370_6 |
Cites_doi | 10.1038/oby.2006.192 10.1007/BF00280883 10.1210/jc.2006-0594 10.2337/diabetes.47.10.1643 10.1016/S0079-6123(03)46018-4 10.1038/oby.2007.591 10.1016/j.ijcard.2006.08.061 10.1016/j.atherosclerosis.2005.08.004 10.1016/j.amjcard.2006.12.042 10.1186/1475-2840-5-1 10.1210/jc.2006-0584 10.1016/j.amjcard.2004.06.075 10.1210/jc.2003-030698 10.1016/j.ejrad.2005.12.030 10.1253/circj.71.536 10.1016/j.carpath.2004.08.005 10.1210/jc.2005-0091 10.1210/jc.2005-1087 10.1161/01.CIR.0000099542.57313.C5 10.1038/ncpcardio0319 10.1161/01.CIR.0000111245.75752.C6 10.1016/j.amjcard.2006.12.082 10.1210/jc.2006-1044 10.1038/oby.2003.45 10.1016/j.amjcard.2006.08.045 10.1016/j.ijcard.2006.04.016 10.1016/j.ahj.2007.03.019 |
ContentType | Journal Article |
Copyright | 2008 North American Association for the Study of Obesity (NAASO) Copyright Nature Publishing Group Apr 2008 |
Copyright_xml | – notice: 2008 North American Association for the Study of Obesity (NAASO) – notice: Copyright Nature Publishing Group Apr 2008 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1038/oby.2008.6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1930-739X |
EndPage | 892 |
ExternalDocumentID | 2725869181 18379565 10_1038_oby_2008_6 OBY937 |
Genre | article Clinical Trial Validation Studies Journal Article |
GroupedDBID | --- 05W 0R~ 123 1OC 29N 2FS 2WC 31~ 33P 39C 3SF 4.4 50Y 52U 52V 53G 70F 8-1 AAESR AAEVG AAFWJ AAHBH AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCUV ABIVO ABJNI ABLJU ABQWH ABXGK ACAHQ ACCZN ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZVAB BAWUL BFHJK BHBCM BKNYI BMXJE BOGZA BPHCQ BRXPI BVXVI CS3 DCZOG DIK DPXWK DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN F5P FUBAC G-S GODZA HGLYW HZ~ KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ O66 O9- OK1 P2W PQQKQ PROAC R.K ROL SUPJJ WBKPD WHG WHWMO WIH WIJ WIK WIN WOHZO WOQ WQJ WVDHM WXSBR YHZ AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE ALIPV CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
ID | FETCH-LOGICAL-c4547-c28a8aa801c9bd5519ac01144e71d58bd77e11d8e3c47fbeb0b35e946ebdae83 |
ISSN | 1930-7381 |
IngestDate | Sun Aug 24 02:53:15 EDT 2025 Fri Jul 25 23:54:49 EDT 2025 Thu Apr 03 06:58:06 EDT 2025 Tue Jul 01 01:15:56 EDT 2025 Thu Apr 24 23:00:10 EDT 2025 Wed Aug 20 07:27:52 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4547-c28a8aa801c9bd5519ac01144e71d58bd77e11d8e3c47fbeb0b35e946ebdae83 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/oby.2008.6 |
PMID | 18379565 |
PQID | 1030423227 |
PQPubID | 105348 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_70442171 proquest_journals_1030423227 pubmed_primary_18379565 crossref_citationtrail_10_1038_oby_2008_6 crossref_primary_10_1038_oby_2008_6 wiley_primary_10_1038_oby_2008_6_OBY937 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2008 |
PublicationDateYYYYMMDD | 2008-04-01 |
PublicationDate_xml | – month: 04 year: 2008 text: April 2008 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: United States – name: Silver Spring |
PublicationTitle | Obesity (Silver Spring, Md.) |
PublicationTitleAlternate | Obesity (Silver Spring) |
PublicationYear | 2008 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2007; 115 1985; 28 2006; 91 2003; 108 2004; 94 2004; 146 1989; 43 2006; 13 2005; 90 2007; 121 2006; 14 2007; 153 2004; 13 2006; 186 2007; 71 2005; 2 2004; 109 2007; 99 2005; 29 2003; 88 2003; 11 1998; 47 2007; 15 2005; 57 Iacobellis G. (e_1_2_6_5_2) 2005; 29 e_1_2_6_30_2 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_12_2 e_1_2_6_13_2 e_1_2_6_11_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_20_2 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 Schejbal V. (e_1_2_6_10_2) 1989; 43 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2 |
References_xml | – volume: 115 start-page: 272 year: 2007 end-page: 273 article-title: Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects publication-title: Int J Cardiol – volume: 57 start-page: 417 year: 2005 end-page: 422 article-title: Mapping epicardial fat with multidetector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation publication-title: Eur J Radiol – volume: 91 start-page: 2906 year: 2006 end-page: 2912 article-title: Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease publication-title: J Clin Endocrinol Metab – volume: 121 start-page: 132 year: 2007 end-page: 134 article-title: Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity publication-title: Int J Cardiol – volume: 91 start-page: 4620 year: 2006 end-page: 4627 article-title: Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance publication-title: J Clin Endocrinol Metab – volume: 13 start-page: 313 year: 2004 end-page: 316 article-title: The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts publication-title: Cardiovasc Pathol – volume: 88 start-page: 5163 year: 2003 end-page: 5168 article-title: Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk publication-title: J Clin Endocrinol Metab – volume: 11 start-page: 304 year: 2003 end-page: 310 article-title: Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction publication-title: Obes Res – volume: 109 start-page: 433 year: 2004 end-page: 438 article-title: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition publication-title: Circulation – volume: 94 start-page: 1084 year: 2004 end-page: 1087 article-title: Relation between epicardial adipose tissue and left ventricular mass publication-title: Am J Cardiol – volume: 153 start-page: 907 year: 2007 end-page: 917 article-title: Human epicardial adipose tissue: a review publication-title: Am Heart J – volume: 108 start-page: 2460 year: 2003 end-page: 2466 article-title: Human epicardial adipose tissue is a source of inflammatory mediators publication-title: Circulation – volume: 146 start-page: 279 year: 2004 end-page: 289 article-title: Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? publication-title: Prog Brain Res – volume: 47 start-page: 1643 year: 1998 end-page: 1649 article-title: Prevalence of insulin resistance in metabolic disorders publication-title: Diabetes – volume: 99 start-page: 1242 year: 2007 end-page: 1245 article-title: Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography publication-title: Am J Cardiol – volume: 28 start-page: 412 year: 1985 end-page: 419 article-title: Homeostasis model assessment: insulin resistance and ‐cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia – volume: 15 start-page: 870 year: 2007 end-page: 878 article-title: Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging publication-title: Obesity – volume: 99 start-page: 1470 year: 2007 end-page: 1472 article-title: Relation of subepicardial adipose tissue to carotid intima‐media thickness in patients with human immunodeficiency virus publication-title: Am J Cardiol – volume: 186 start-page: 354 year: 2006 end-page: 359 article-title: Subepicardial adipose tissue and the presence and severity of coronary artery disease publication-title: Atherosclerosis – volume: 90 start-page: 6300 year: 2005 end-page: 6302 article-title: Epicardial adipose tissue and insulin resistance in obese subjects publication-title: J Clin Endocrinol Metab – volume: 14 start-page: 1679 year: 2006 end-page: 1684 article-title: Different “weight” of cardiac and general adiposity in predicting left ventricle morphology publication-title: Obesity – volume: 29 start-page: 251 year: 2005 end-page: 255 article-title: Adiponectin expression in human epicardial adipose tissue is lower in patients with coronary artery disease publication-title: Cytokine – volume: 90 start-page: 3978 year: 2005 end-page: 3982 article-title: Endothelial function, carotid artery intima‐media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone‐deficient adolescents: apparent effects of growth hormone treatment on these parameters publication-title: J Clin Endocrinol Metab – volume: 43 start-page: 490 year: 1989 end-page: 499 article-title: Epicardial fatty tissue of the right ventricle: morphology, morphometry and functional significance publication-title: Pneumologie – volume: 91 start-page: 4689 year: 2006 end-page: 4695 article-title: Myocardial triglyceride content and epicardial adipose mass in human obesity: relationship to left ventricular function and serum free fatty acid levels publication-title: J Clin Endocrinol Metab – volume: 2 start-page: 536 year: 2005 end-page: 543 article-title: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart publication-title: Nat Clin Pract Cardiovasc Med – volume: 71 start-page: 536 year: 2007 end-page: 539 article-title: Echocardiographic epicardial fat thickness and coronary artery disease publication-title: Circ J – volume: 13 start-page: 1 year: 2006 article-title: Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease publication-title: Cardiovasc Diabetol – volume: 99 start-page: 541 year: 2007 end-page: 548 article-title: Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations publication-title: Am J Cardiol – ident: e_1_2_6_3_2 doi: 10.1038/oby.2006.192 – ident: e_1_2_6_25_2 doi: 10.1007/BF00280883 – ident: e_1_2_6_23_2 doi: 10.1210/jc.2006-0594 – ident: e_1_2_6_26_2 doi: 10.2337/diabetes.47.10.1643 – ident: e_1_2_6_8_2 doi: 10.1016/S0079-6123(03)46018-4 – ident: e_1_2_6_28_2 doi: 10.1038/oby.2007.591 – ident: e_1_2_6_27_2 doi: 10.1016/j.ijcard.2006.08.061 – ident: e_1_2_6_19_2 doi: 10.1016/j.atherosclerosis.2005.08.004 – ident: e_1_2_6_22_2 doi: 10.1016/j.amjcard.2006.12.042 – ident: e_1_2_6_7_2 doi: 10.1186/1475-2840-5-1 – ident: e_1_2_6_17_2 doi: 10.1210/jc.2006-0584 – volume: 43 start-page: 490 year: 1989 ident: e_1_2_6_10_2 article-title: Epicardial fatty tissue of the right ventricle: morphology, morphometry and functional significance publication-title: Pneumologie – ident: e_1_2_6_12_2 doi: 10.1016/j.amjcard.2004.06.075 – ident: e_1_2_6_15_2 doi: 10.1210/jc.2003-030698 – ident: e_1_2_6_29_2 doi: 10.1016/j.ejrad.2005.12.030 – ident: e_1_2_6_18_2 doi: 10.1253/circj.71.536 – ident: e_1_2_6_11_2 doi: 10.1016/j.carpath.2004.08.005 – ident: e_1_2_6_21_2 doi: 10.1210/jc.2005-0091 – ident: e_1_2_6_14_2 doi: 10.1210/jc.2005-1087 – ident: e_1_2_6_6_2 doi: 10.1161/01.CIR.0000099542.57313.C5 – ident: e_1_2_6_2_2 doi: 10.1038/ncpcardio0319 – ident: e_1_2_6_24_2 doi: 10.1161/01.CIR.0000111245.75752.C6 – ident: e_1_2_6_16_2 doi: 10.1016/j.amjcard.2006.12.082 – volume: 29 start-page: 251 year: 2005 ident: e_1_2_6_5_2 article-title: Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease publication-title: Cytokine – ident: e_1_2_6_9_2 doi: 10.1210/jc.2006-1044 – ident: e_1_2_6_20_2 doi: 10.1038/oby.2003.45 – ident: e_1_2_6_30_2 doi: 10.1016/j.amjcard.2006.08.045 – ident: e_1_2_6_13_2 doi: 10.1016/j.ijcard.2006.04.016 – ident: e_1_2_6_4_2 doi: 10.1016/j.ahj.2007.03.019 |
SSID | ssj0046051 |
Score | 2.3607845 |
Snippet | Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and... Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and... Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target.... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 887 |
SubjectTerms | Adult Aged Echocardiography - methods Echocardiography - standards Echocardiography - statistics & numerical data Female Humans Insulin Resistance Intra-Abdominal Fat - diagnostic imaging Male Metabolic Syndrome - diagnostic imaging Metabolic Syndrome - epidemiology Middle Aged Obesity - diagnostic imaging Obesity - epidemiology Observer Variation Pericardium - diagnostic imaging Reference Values Risk Factors ROC Curve Sensitivity and Specificity |
Title | Threshold Values of High‐risk Echocardiographic Epicardial Fat Thickness |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1038%2Foby.2008.6 https://www.ncbi.nlm.nih.gov/pubmed/18379565 https://www.proquest.com/docview/1030423227 https://www.proquest.com/docview/70442171 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELbKIiEuiH-yu0AkkBCKUpLajZ0joC67RYXDFrScIsdxpIpVUm2bw3LiBZB4Rp6EGTt_pRVauESV69Sp5_N4ZvxlhpDnlEUiDVLppxlPfUZz5YNnq3wwNrIsj5lgEuMdsw_R8Sc2PRufDQY_eqylap0O1bed75X8j1ShDeSKb8n-g2TbH4UG-AzyhStIGK5XlDE4y3h-5H2W55VNH4vEjZbBYIjjE9BwytBOTXbqhfImy4VpAPEcyTXW7lRfi4aKUVuqdcUAtEBPF0if9mwM0ERQs2EvgnACShWPL2y2gneAN6yk1g_oaGusW4quNx124VM87CjtbdVKL5ctzE5NSm2juS4upTcbboQnRI_VYjVqTAOfU1uXZaj7baaGbqeGox7cWE-ninpHrrdnWzpvS_PbPO9lemn5sTvSa_-x7bVkRHMMT0UC99qinNE1cn3EwRRDG_vkfbOx4wlyaEkK9h812W6peNWNu2nfbDktmz6QMWLmt8mt2vtwX1so3SEDXdwlN2Y1v-IembaIci2i3DJ3EVG_vv9ELLlbWHI7LLmAJbfF0n0yP5rM3x77dbUNX2FSN1-NhBRSgsWi4jQDQzqWCr1lpnmYjQWsZa7DMBOaKsbzVMMKp2Mds0inmdSCPiB7RVnoR8TlgQypDDXlucTwgQhinUkZBjofM5glh7xspihRdSZ6LIhynmyLwiHP2r5Lm39lZ6_DZqaTen2usA-SvkYj7pCn7degPfFITBa6rFYJDxgDpzx0yEMrn24QQXkM3o5DXhiB_WX05OObL2Dl71_pUQ_IzW6ZHJK99UWlH4Ndu06fGLT9BhP1oXE |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Threshold+Values+of+High%E2%80%90risk+Echocardiographic+Epicardial+Fat+Thickness&rft.jtitle=Obesity+%28Silver+Spring%2C+Md.%29&rft.au=Iacobellis%2C+Gianluca&rft.au=Willens%2C+Howard+J.&rft.au=Barbaro%2C+Giuseppe&rft.au=Sharma%2C+Arya+M.&rft.date=2008-04-01&rft.issn=1930-7381&rft.eissn=1930-739X&rft.volume=16&rft.issue=4&rft.spage=887&rft.epage=892&rft_id=info:doi/10.1038%2Foby.2008.6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_oby_2008_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1930-7381&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1930-7381&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1930-7381&client=summon |